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Fungal pathogenesis requires a number of extracellularly released virulence factors. Recent studies
demonstrating that most fungal extracellular molecules lack secretory tags suggest that unconventional
secretion mechanisms and fungal virulence are strictly connected. Proteins of the endosomal sorting
complex required for transport (ESCRT) have been recently associated with polysaccharide export in the
yeast-like human pathogen Cryptococcus neoformans. Snf7 is a key ESCRT operator required for
unconventional secretion in Eukaryotes. In this study we generated snf7D mutant strains of C. neoformans
and its sibling species C. gattii. Lack of Snf7 resulted in important alterations in polysaccharide secretion,
capsular formation and pigmentation. This phenotype culminated with loss of virulence in an intranasal
model of murine infection in both species. Our data support the notion that Snf7 expression regulates
virulence in C. neoformans and C. gattii by ablating polysaccharide and melanin traffic. These results are in
agreement with the observation that unconventional secretion is essential for cryptococcal pathogenesis and
strongly suggest the occurrence of still obscure mechanisms of exportation of non-protein molecules in
Eukaryotes.
C
ryptococcosis is the leading cause of human deaths related to fungal infections in Africa1. This disease is
caused by the yeast-like pathogens Cryptococcus neoformans and C. gattii. The former is an opportunistic
fungal pathogen that causes highly lethal meningitis in immunocompromised individuals2. C. gattii, on
the other hand, can infect both immunocompromised and immunocompetent individuals3.
The progress of cryptococcal disease relies on several extracellular virulence factors4,5, implying that secretion is
fundamental for cryptococcal pathogenesis. Eukaryotic molecules are exported through different cellular path-
ways, including conventional and unconventional secretory routes6,7. Conventionally secreted proteins follow the
classical endoplasmic reticulum (ER)/Golgi-dependent secretory pathway7. Protein secretion through conven-
tional mechanisms is dependent of an N-terminus-linked signal peptide, which is responsible for translocation of
polypeptides into the lumen of the ER7. Proteins that lack a typical signal peptide are transported independently of
this classical ER-Golgi route and engage the so-called unconventional secretion mechanisms6.
Most of the pathogenic determinants of C. neoformans lack secretory tags, supporting the notion that uncon-
ventional pathways of secretion are required for cryptococcal virulence8. C. neoformans and C. gattii export
massive amounts of polysaccharides to the extracellular milieu9,10. Polysaccharide export is required for capsule
formation, which is essential for the survival of cryptococci in host tissues11–14. The main component of the
polysaccharide capsule is glucuronoxylomannan (GXM). GXM is co-transported to the extracellular space with
other virulence factors inside vesicles that traverse the cell wall15–17. Although the morphological aspects of these
vesicles suggest that they are similar to mammalian exosomes, their cellular origin remains undetermined
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The eukaryotic sucrose non-fermenting protein 7 (Snf7) is a key
operator in the endosomal sorting complex required for transport
(ESCRT)-III19,20. This molecular complex, in association with other
ESCRT components, is involved in multivesicular body (MVB)
formation and cargo. MVB formation requires Snf7 oligomerization
into a membrane-associated filament, which is nucleated by its asso-
ciation with the vacuolar protein sorting regulator Vps2021. MVBs,
which derive from late endosomes, can be directed for fusion with the
plasma membrane, resulting in extracellular release of their luminal
vesicles, the so-called exosomes22,23. The ESCRT machinery has also
been implicated in environmental pH sensing and adaptation in
various fungal species through mechanisms that require the
RIM101 pathway, a signaling mechanism necessary for the regu-
lation of alkaline environment-related genes24,25. Recently, the
RIM101-mediated stress response has been demonstrated to be up
regulated during human meningitis caused by C. neoformans26. The
supposition that MVBs are associated with the export of virulence
factors in C. neoformans17 and the fact that adaptation to alkaline
pHs is required for fungal survival in both alveolar spaces and the
bloodstream27 suggests that SNF7 is involved in cryptococcal
pathogenicity.
In this work we generated C. neoformans and C. gattii snf7D
mutant strains and characterized their biological and pathogenic
properties. Lack of Snf7 affected key virulence determinants in both
C. neoformans and C. gattii. This phenotype culminated with loss of
virulence in an intranasal model of murine infection in both species.
These results strongly support the hypothesis that unconventional
secretion pathways are essential for the pathogenesis of C. neofor-
mans and C. gattii.
Results
Snf7-related sequences in C. neoformans and C. gattii. A data-
base search of the C. gattii genome (http://www.broadinstitute.org/
annotation/genome/cryptococcus_neoformans_b/MultiHome.html-
August 5, 2009, strain R265) revealed that the SNF7 (accession
number CNBG_3856) coding region comprises 1,087 bp, includes
five introns, and encodes a protein of 221 amino acids. A similar
search in the C. neoformans genome (http://www.broadinstitute.org/
annotation/genome/cryptococcus_neoformans/MultiHome.html)
identified the putative SNF7 sequence (accession number CNAG_
01583.2) based on the similarity to the corresponding C. gattii
sequence (accession number CNBG_3856). The C. neoformans
SNF7 ortholog is 1,413 bp long, contains five introns, and also
encodes a putative 221 amino-acid protein. Phylogenetic analysis
of Snf7 was performed with orthologues from distinct eukaryotic
organisms (Figure 1A). The putative sequence of the C. gattii
protein was highly similar to its C. neoformans counterpart (98%
identity) and both display similarities to plant proteins (A. thaliana
,35% identity; O. sativa ,24% identity). In comparison to other
fungi, the Snf7 sequences of both species studied here showed 45%
identity with the S. cerevisiae protein and 43% identity with a C.
albicans homologue.
Disruption and complementation of SNF7 genes in both C. neo-
formans and C. gattii. To analyze the functions of SNF7, we
generated snf7D disruption mutants in the backgrounds of the
standard strains H99 (serotype A isolate of C. neoformans) and
R265 (serotype B isolate of C. gattii). These mutant strains were
called CN-snf7D and CG-snf7D, respectively. To ensure that the
eventual phenotypes observed in the mutant strains were due to
the knockout of the SNF7 gene, we constructed the complemented
strains (CN-snf7D::SNF7 for C. neoformans and CG-snf7D::SNF7 for
C. gattii) by integrating a wild-type copy of the SNF7 gene into the
genome of the mutant strains. Deletion and complementation of
SNF7 in both species were confirmed by Southern blot analysis
(Figure 1B) and RT-PCR (Figure 1C).
Growth rates of the snf7D mutants under different conditions. We
first evaluated whether the growth rates of the snf7D strains varied
under different conditions. C. neoformans and C. gattii mutant
strains showed normal growth at both 30 and 37uC, in comparison
to parental and reconstituted strains (Figure 2A). Since copper
acquisition is important for C. neoformans melanization and
capsule formation28,29 we also evaluated the ability of the snf7D
mutants to grow under copper deprivation conditions. Once again,
the mutants showed normal growth rates, in comparison to WT and
complemented cells (Figure 2B).
The ESCRT machinery, including Snf7, plays a central role in
resistance to higher pHs and tolerance to ionic lithium30–32.
Therefore, we analyzed the ability of the snf7D mutants to survive
under these conditions. Analysis of fungal growth in pHs ranging
from 7 to 9 suggested lower growth rates of both CN-snf7D and CG-
snf7D in pHs above 7.5, in comparison to parental and reconstituted
cells (Figure 2C; p , 0.05 for all comparisons between cells expres-
sing Snf7 and snf7D strains). A similar result was obtained when the
C. neoformans and C. gattii strains were cultivated in the presence of
150 mM LiCl2 (Figure 2D). The phenotypes described above in C.
neoformans and other fungal species are related to the interaction
between Snf7 and molecules belonging to the RIM101 pathway
(Figure 3A), which includes Rim101p and Rim20p30,33–35. There-
fore, to support the notion that the phenotypes we observed were
linked to defects in Rim101p activation via interaction with Snf7/
Rim20p we assessed the expression of RIM101 and RIM20. We
observed that although the mRNA levels of RIM20 remained the
same for all strains, the expression of RIM101 was significantly lower
in both snf7D mutants (Figure 3B and C). This observation is in
agreement with a lower activation of RIM101p due to lack of Snf7.
SNF7 disruption alters pigmentation but not urease and phos-
pholipase activities. Extracellularly released enzymes and exported
pigments are fundamental for cryptococcal pathogenesis5,17,36–39.
Therefore, we analyzed whether SNF7 disruption would impact
melanization and the extracellular activities of urease and phospho-
lipase. Pigmentation was evaluated visually after growth of C.
neoformans and C. gattii on both Niger seed and L-DOPA-
containing solid media (Figure 4A). Under both conditions, the
CN-snf7D mutant strain was similar to parental (WT) and comple-
mented (reconstituted) strains in its ability to melanize at 30uC.
However, when cultivated at 37uC, the mutant CN-snf7D showed
reduced pigmentation. Differently, the CG-snf7D mutant showed
subtle melanization defects when cultivated on L-DOPA agar at
30uC. At 37uC, the pigmentation defects were more evident. On
Niger seed agar, SNF7 deletion in C. gattii affected pigmentation at
30uC, but not at 37uC. These results revealed an unexpected inter-
species diversity in the relationship between Snf7 and pigmentation.
Crude phospholipase activity was also assessed in the SNF7 dis-
ruption model. Although the rate of phospholipid hydrolysis showed
some tendency to be higher in the CN-snf7D mutant, there were no
statistical differences between any of the C. neoformans strains
(Figure 4B). The C. gattii snf7 mutant showed levels of phospholipase
activity that tended to be lower than those observed for parental and
complemented strains (Figure 4B). Urease activity was similar in all
strains analyzed in this study (Figure 4C).
Lack of Snf7 severely impairs GXM secretion and capsule for-
mation. GXM secretion and capsule enlargement are essential for
cryptococcal pathogenesis (reviewed in40). Since it has been suggest-
ed that GXM is exported by unconventional secretion mechanisms
(reviewed elsewhere9,15,41), we evaluated whether SNF7 deletion
affects capsule size and extracellular polysaccharide secretion.
Quantification of secreted GXM in all strains by ELISA revealed
that deletion of SNF7 nearly extinguished polysaccharide export in
both C. neoformans and C. gattii (Figure 5A). Morphological analysis
of the capsule by India ink counterstaining, immunostaining of GXM
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and scanning electron microscopy revealed a clear reduction in cap-
sular dimensions in the snf7D mutants (Figure 5B), implying defects
in capsular assembly. Determination of the capsule/cell diameter
ratio confirmed a significant reduction (p , 0.0001) in capsular
dimensions in both CN-snf7D and CG-snf7D cells (Figure 5C).
snf7D mutants are avirulent in a murine infection model. The
involvement of Snf7 in melanization, polysaccharide secretion and
capsule assembly was in agreement with the possibility that SNF7
deletion could affect pathogenesis. To address this question, mice
were infected intranasally with each strain used in this work for
mortality assessment. The totality of animals infected with wild
type and CN-snf7D::SNF7 reconstituted strains died by day 14 post
infection (Figure 6A). Infection of mice with the CN-snf7D strain,
however, resulted in nearly 63% survival at day 40-post infection,
when animals were sacrificed. Animals infected with the C. gattii
snf7D mutant had a survival rate of 87.5% by day 40 (Figure 6B).
Mice infected with parental and complemented strains of C. gattii
died by days 18 and 29, respectively. Statistical analysis (Mantel-Cox
test) confirmed that C. neoformans (p 5 0.0065) and C. gattii (p 5
0.0008) cells lacking Snf7 were less efficient than parental and
complemented strains in killing mice.
To assess GXM secretion in vivo, mice were infected with C. neo-
formans for determination of fungal loads and polysaccharide con-
centration in lung tissues (Figure 6C). In pulmonary samples from
infected mice with the CN-snf7D mutant, the concentration of extra-
cellular GXM was nearly half the values obtained when mice were
infected with parental cells (p 5 0.0017). Fungal loads were also
greatly reduced when animals were infected with the CN-snf7D
mutant, in comparison to animals infected with the wild type strain
(p , 0.0001).
Discussion
Secretory activity is mandatory for cryptococcal pathogenesis. The
vast majority of the well-characterized molecular determinants of
cryptococci are extracellular, including GXM, urease and phospho-
lipase B17,37,42–44. In addition, C. neoformans melanin, which is also
fundamental for virulence, is exported to the cell surface by vesicle-
dependent secretory mechanisms17,45. Except for phospholipase B, all
the above-mentioned virulence factors lack the leader peptide
Figure 1 | Analysis of cryptococcal SNF7. (A). Phylogenetic analysis was performed by applying the neighbor-joining method with Snf7 amino acid
sequences from distinct organisms as follows: S. cerevisiae, C. albicans, A. nidulans, P. brasiliensis, S. pombe, N. crassa, M. oryzae, A. thaliana, O. sativa, C.
neoformans and C. gattii. The bar marker indicates the genetic distance, which is proportional to the number of amino acid substitutions. Bootstrap
values obtained with 1,000 re-samplings are displayed at the nodes. (B). Analysis of SNF7 disruption in C. neoformans and C. gattii by Southern blot.
Genomic DNA (10 mg) from WT, snf7D and snf7D::SNF7 strains were digested with the Xbal restriction enzyme. The 39 gene flank was used as probe in
Southern hybridization. (C). For RT-PCR, cDNA from C. neoformans and C. gattii (WT, snf7D and snf7D::SNF7 strains) were used as template and
genomic DNA of both fungi (WT cells) was used as positive control. Actin gene (ACT1) was used as reference gene for normalization of RT-PCR.
www.nature.com/scientificreports
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Figure 2 | Effects of SNF7 disruption on fungal growth under different conditions. (A). Wild type (WT), mutant (snf7D) and complemented
(snf7D::SNF7) strains of C. neoformans and C. gattii were grown in YPD broth with shaking at 30uC or 37uC. Growth measurements (OD600) were
performed at 4 h, 6 h, 8 h, 10 h, 12 h and 24 h. (B). Ten-fold serial dilutions of all strains were plated on LCM 1 Cu and LCM agar plates. The plates were
incubated for 2 days at 30uC or 37uC. Fungal growth in LCM 1 Cu represented the control condition. (C). Growth rates of WT, mutant and
complemented strains at pHs 7, 7.5, 8, 8.5 and 9. (D). Growth of WT, snf7D and snf7D::SNF7 strains on YPD agar plates supplemented with 150 mM
LiCl2. Experiments were performed in triplicate and representative examples are shown.
www.nature.com/scientificreports
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required for conventional secretion46. This observation and the
recent notion that most fungal extracellular molecules lack secretory
tags17 strongly suggest that unconventional secretion mechanisms
and fungal virulence are strictly connected. Due to high efficacy of
both C. neoformans and C. gattii in exporting massive amounts of
polysaccharides, we used this model to investigate connections be-
tween unconventional export of molecules and fungal pathogenesis.
The ESCRT machinery participates in MVB formation (reviewed
in23,47), which is required for exosome release to the extracellular
space. Snf7, one of the components of the ESCRTIII protein complex,
is responsible for the genesis of intraluminal vesicles of MVBs47.
Therefore, considering that fungal cells might use exosome-like vesi-
cles for the transfer of intracellularly synthesized polysaccharides to
the extracellular milieu17, it seems reasonable to suppose that Snf7 is
required for unconventional export of GXM in fungal cells. This
hypothesis is supported by the fact that C. neoformans sec mutants,
which have defects in post-Golgi, conventional secretory mechan-
isms, have normal capsules48,49. On the other hand, C. neoformans
ESCRT-I mutants lacking expression of Vps23 manifested defective
capsule formation and reduced virulence in a mouse model of
cryptococcosis50.
Most of the studies on secretory mechanisms in eukaryotic cells
were focused on protein trafficking17,48,51–55. The mechanism for
export of molecules of a non-protein nature, including pigments
and polysaccharides, are poorly known. In mammalian cells,
MVBs have been correlated with the initial biogenesis of melano-
somes56, implying connections between unconventional secretion
and pigment traffic. In plant cells, endomembranes participate in
polysaccharide traffic57, but the identity of the components necessary
for the transport of cell wall enzymes and polysaccharides is not
known. In this study, deletion of SNF7 resulted in reduced efficacies
of pigmentation, GXM secretion and capsule formation in C. neofor-
mans and C. gattii. These observations suggest that MVB formation
and unconventional secretion mechanisms participate directly in the
export of surface and/or extracellular molecules of non-protein nat-
ure. Although this hypothesis still needs experimental confirmation,
it agrees with the observation that in C. neoformans Golgi reassembly
and stacking protein (GRASP) and the Apt1 flippase, which are both
unconventional secretion regulators, were required for polysacchar-
ide, but not protein export58–60.
Melanin is essential for cryptococcal virulence61. In our study, the
effects of SNF7 deletion on melanin formation varied depending on
the species analyzed, temperature of growth and source of substrates
for pigment synthesis. This observation efficiently illustrates the
physiological diversity between the sibling species C. neoformans
and C. gattii, which is likely linked to their well-known differences
in pathogenic potential3. These results also exemplify the functional
diversity of Snf7 in eukaryotes. In our model, fungal growth was only
Figure 3 | SNF7 disruption affects the expression of RIM101. (A). Conceptual basis for the analysis of Rim101 and Rim20 expression in
C. neoformans and C. gattii strains. Rim101 activation depends on the recruitment of ESCRTI, ESCRTII and ESCRTIII components (Vps20 and Snf7) to
the cytoplasmic face of the endosomal membrane. The Snf7 and Rim20/Rim13 protein complex interacts with the Rim101 precursor, which is further
cleaved to release the active form of Rim101. This process results in the regulation of cryptococcal genes playing key roles in a number of cellular events.
Adapted from Selvig and Alspaugh87. Expression levels of RIM101 and RIM20 were assessed in wild-type (WT), mutant (snf7) and complemented
(snf7::SNF7) strains of C. neoformans (B) and C. gattii (C). The expression levels were normalized to the wild-type using the 22DDCt 88.The experiments
were performed with two biological samples, and each cDNA sample was analyzed in triplicate with each primer pair. (*, p , 0.05 in comparison with WT
and complemented cells).
www.nature.com/scientificreports
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slightly affected in mutants cultivated at 37uC, but a previous study
with S. cerevisiae lacking Snf7 demonstrated a clear correlation
between carbon source and temperature-sensitive growth62, suggest-
ing an important metabolic variation that is affected by both nutrient
availability and temperature of growth. The mechanisms explaining
the differential ability of C. neoformans and C. gattii Snf7 mutants to
produce pigments at different temperatures in the presence of dis-
tinct melanization substrates are still unknown, but our results and
the seminal observations in the S. cerevisiae model62 clearly support
the notion that the physiological functions of Snf7 are regulated at
multiple levels and result in variable fungal phenotypes. It is note-
worthy that the enzymatic activity required for melanization can be
also influenced by pH. Due to the putative roles of Snf7 in pH sens-
ing21,30, we cannot rule out the hypothesis that defective melanin
formation resulted from altered laccase activity in the two species
analyzed in our study.
SNF7 deletion also interfered with tolerance to alkaline pH and
high lithium chloride concentrations. This data is in agreement with
previous literature on S. cerevisiae63, C. albicans25,64 and A. nidulans65
suggesting the participation of Snf7 in the RIM101 signaling cascade.
The RIM family includes a sensor protein (RIM21p) and a catalytic
complex (RIM20p in association with RIM13p) capable of inducing
the proteolytic activation of RIM101p. The lack of Snf7 has been
correlated with inability to activate the RIM101 transcription factor
independently of the presence of RIM20p and RIM13p25,35,64. In fact,
the active form of Rim101p supposedly modulates the expression of
Figure 4 | Disruption of SNF7 affects pigmentation but not extracellular enzyme activity. (A). Fungal cells were grown on Niger seed agar and L-DOPA
plates to evaluate melanin production by wild-type (WT), mutant (snf7D) and complemented (snf7D::SNF7) strains of C. neoformans and C. gattii. The
cultures were incubated at 30uC and 37uC and monitored for 2 (Niger), 3 (L-DOPA 30uC) or 4 (L-DOPA 37uC) days of cultivation. (B). Phospholipase
activity in egg yolk agar. All strains were inoculated on plates containing egg yolk agar and incubated at 30uC for 4 days, and Pz values were then
determined. (C). Urease activity levels of WT, snf7D, snf7D::SNF7 cells. Fungal cells were incubated in urea broth with shaking (200 rpm) at 37uC for
24 hours for colorimetric determination. Statistical differences were not observed when parental, mutant and complemented strains were compared.
www.nature.com/scientificreports
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several genes involved in the adaptation to different environments66
and its own expression, which is in agreement with the reduction of
RIM101 mRNA observed in our study.
O’Meara and collaborators have recently shown that Rim101p is
also essential for capsule enlargement in C. neoformans35. Although a
rim101D mutant had normal GXM secretion, several genes involved
in cell wall-biosynthesis were affected by RIM101 deletion, which was
likely related to a hypocapsular phenotype35. The mutant retained
virulence in a murine intranasal infection model, suggesting that
secretion of GXM could sufficiently impact host cells in favor of
the pathogenic process35. The results obtained in our study are in
agreement with this supposition. It is noteworthy, however, that the
SNF7 disruption mutants generated in this work additionally had
reduced capsules and low efficacy to melanize, which likely renders
these cells more susceptible to the antimicrobial arsenal produced by
the host. Future studies on how SNF7 and RIM101 impact immuno-
modulation are necessary for a broader understanding on how these
cellular pathways interfere with the pathogenic process.
Figure 5 | Surface architecture and GXM release are affected by SNF7 deletion. (A). Determination of GXM in C. neoformans and C. gattii culture
supernatants. Asterisks denote statistically significant differences (**, p , 0.005; ***, p , 0.001) between the values obtained for the mutant strains and
those obtained for wild type (WT) and complemented (snf7D::SNF7) cells. (B). Microscopic analysis of WT, snf7D and snf7D::SNF7 strains of C.
neoformans and C. gattii. India ink counterstaining and immunostaining (upper and middle panels, respectively) revealed that SNF7 disruption
profoundly affects capsule formation. GXM and chitin are stained in green and blue respectively (middle panels). Scale bars represent 5 mm. Scanning
electron microscopy of the C. neoformans and C. gattii strains (Lower panels). Scale bar represents 1 mm. (C). Quantification of capsular dimensions
based on in silico measurements of the results illustrated in B (***, p , 0.001).
Figure 6 | Cryptococcal virulence is affected by SNF7 disruption. Mortality rates of mice lethally infected with wild type (WT), mutant (snf7D) and
complemented (snf7D::SNF7) strains of C. neoformans (A) and C. gattii (B) were monitored daily. SNF7 deletion was associated with a non-virulent
phenotype in both cryptococcal species. Determination of GXM concentration (black bars) and lung CFU counts (grey bars) in the lungs of mice infected
with wild type (CN-WT) and mutant (CN-snf7D) cells (C) revealed defective polysaccharide production and reduced survival of the mutant
(**, p 5 0.0017; ***, p , 0.0001).
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Our observations support the notion that Snf7 expression regu-
lates virulence in both C. neoformans and C. gattii by reducing poly-
saccharide and melanin traffic. These results further support the
observation that unconventional secretion is essential for cryptococ-
cal pathogenesis18,58,67 and strongly suggests the occurrence of still
obscure mechanisms of exportation of molecules of a non-protein
nature in Eukaryotes.
Methods
Fungal strains, plasmids and media. The C. neoformans strain H99 (serotype A) and
the C. gattii strain R265 (serotype B) were the recipients for construction of the
mutant strains. Cells were maintained in YPD medium (yeast extract 1%, peptone 2%,
glucose 2% and 1.5% agar). To evaluate the effects of Cu21 deprivation on C.
neoformans and C. gattii, cells were grown in 10 mL of YPD broth previous to a
further cultivation in 100 mL of Yeast Nitrogen Base broth (YNB) (Becton,
Dickinson and Company, Sparks, USA) for 24 hours at 37uC. The cells (5 3
107 cells.mL21) were then transferred to 50 mL of limited Cu21medium (LCM) and of
Cu21-replete medium (LCM 1 Cu) for 12 hours at 37uC with shaking (200 rpm).
LCM is identical to a previously described low iron medium (LIM)68, except for
supplementation with 100 mM bathocuproine disulphonate (BCS) (Sigma Chemical
Co., Saint Louis, USA) and 100 mM FeHEDTA (Sigma Chemical Co., Saint Louis,
USA). LCM 1 Cu was prepared based on the composition described for iron-replete
medium (LIM 1 Fe)68,69. YPD plates with nourseothricin (100 mg/mL) were used to
select C. neoformans SNF7 deletion transformants (CN-snf7D). YPD plates with
hygromycin (200 mg/mL) were used to select C. neoformans SNF7 complementation
transformants (CN-snf7D::SNF7). For C. gattii, YPD plates supplemented with
hygromycin (200 mg/mL) were used to select the SNF7 deletion transformants
(CG-snf7D). YPD plates with supplemented nourseothricin (100 mg/mL) were used
to select complemented transformants (CG-snf7D::SNF7). Plasmid pJAF1570 was the
source of a hygromycin resistance cassette and pAI471 was the source of a
nourseothricin resistance cassette. Plasmids were maintained in Escherichia coli
grown at 37uC for 18 hours in LB broth or agar supplemented with 50 mg/mL of
kanamycin.
In silico analysis of C. neoformans and C. gattii SNF7 orthologs. The C.
neoformans putative SNF7 gene sequence (Broad Institute accession number
CNAG_01583.2) was identified by a BLAST search in the C. neoformans var. grubii
strain H99 genomic database at the Broad Institute database by using the SNF7
sequence of C. gattii (Broad Institute accession number CNBG_3856). The putative
amino acid sequences of Snf7 functional homologs in Saccharomyces cerevisiae
(NCBI accession number P39929.1), Candida albicans (NCBI accession number
EEQ43071.1), Aspergillus nidulans (Broad Institute accession number ANID_04240),
Paracoccidioides brasiliensis (Broad Institute accession number PAAG_07890.1),
Schizosaccharomyces pombe (NCBI accession number Q9P7F7), Neurospora crassa
(Broad Institute accession number NCU01282.5), Magnaporthe oryzae (NCBI
accession number EHA47375.1), Arabidopsis thaliana (NCBI accession number
AEE85595.1), Oryza sativa (NCBI accession number AAT85290.1), C. neoformans
(Broad Institute accession number CNAG_01583.2) and C. gattii (Broad Institute
accession number CNBG_3856) were aligned using Clustal X272. Phylogenetic
analysis was performed using Mega5 applying the neighbor-joining method73. Tree
architecture was inferred from 1,000 bootstraps.
Disruption and complementation of SNF7. Delsgate methodology74–76 was used to
construct the snf7D mutant strains. For the C. neoformans mutant, pDONRNAT
vector was constructed as previously described76. The 59 and 39 SNF7 flanks
(,700 bp) were PCR amplified and gel purified using the Illustra GFX PCR DNA
and gel band purification kit (GE Healthcare, Fairfield, USA). pDONRNAT
(,300 ng) plus 59 and 39 PCR products (,30 ng of each) were submitted to BP
clonase reaction, according to manufacturer’s instructions (Invitrogen, Carlsbad,
USA). This reaction mixture was transformed into Escherichia coli OmniMAX 2-
T177. The deletion construct was linearized by I-SceI enzymatic digestion and
submitted to biolistic transformation78 in C. neoformans (H99 strain). The
possible snf7D mutant colonies were screened by PCR, and the deletion was
confirmed by Southern blot analysis and reverse transcription-PCR (RT-PCR).
For complementation of the SNF7 mutant, a genomic PCR fragment containing a
wild type C. neoformans SNF7 gene was cloned into the SmaI site of pJAF15
plasmid. Biolistic transformation was performed to introduce the resultant vector
into snf7D mutant strain. Genomic insertion was confirmed by Southern blot and
RT-PCR.
The generation of the C. gattii mutant and complemented strains was performed as
described above for C. neoformans with some modifications. For the mutant strain, a
hygromicin resistance cassette was used to construct pDONRHYG, which was
transformed into E. coli TG2 cells. The mutant strains were screened and confirmed
as described above. For complementation, a genomic PCR fragment containing the
wild-type C. gattii SNF7 gene was cloned into the SmaI site of the pAI4 plasmid.
Genomic insertion was confirmed via Southern blot and RT-PCR.
Primers used to construct and confirm mutant and complemented strains are listed
in Table 1.
Phenotypic assays. For spot assays, wild type C. neoformans and C. gattii (CN-WT
and CG-WT), CN-snf7D and CG-snf7D mutants and complemented (CN-
Table 1 | List of primers used to construct mutant (snf7D) and complemented (snf7D::SNF7) strains of C. neoformans and C. gattii
Primer name Sequence (59- 39) Purpose
CnSNF75F GGGACCACTTTGTACAAGAAAGCTGGGTAATCTTTCACGATGTTGTTTC Disruption construct for SNF7, 59 flank
CnSNF75R GGGGACAAGTTTGTACAAAAAAGCAGGCTATTGATACTTATGTCTCGACTA Disruption construct for SNF7, 59 flank
CnSNF73F GGGGACCACTTTGTACAAGAAAGCTGGGTAATCTTTCACGATGTTGTTTC Disruption construct for SNF7, 39 flank
CnSNF73R AAAAATTACCCTGTTATCCCTTAACCATTGACGAAACCACCGT Disruption construct for SNF7, 39 flank
CnSNF7compF CAGATATCCATCACACTGGCGGCCCGTATGGCAATTTCTCATCC Amplification of SNF7 for
complementation
CnSNF7compR ACTCACTATAGGGCGAATTGGGCCCCCAATGACACCTGTGCCA Amplification of SNF7 for
complementation
CnRTSNF7F GGGACCACTTTGTACAAGAAAGCTGGGTAATCTTTCACGATGTTGTTTC Amplification of SNF7 for RT-PCR
CnRTSNF7R GCGCCAACAGTTATTGATGCT Amplification of SNF7 for RT-PCR
CgSNF75F AAAATAGGGATAACAGGGTAATGATCCTGCGTGGAATGAACAA Disruption construct for SNF7, 59 flank
CgSNF75R GGGGACAAGTTTGTACAAAAAAGCAGGCTATCACATCTAATCGAATCGCTTTC Disruption construct for SNF7, 59 flank
CgSNF73F GGGGACCACTTTGTACAAGAAAGCTGGGTAGTGTCGATGCTACAATGGACA Disruption construct for SNF7, 39 flank
CgSNF73R AAAAATTACCCTGTTATCCCTAGAGGTGGGTTGCTAACCGTAG Disruption construct for SNF7, 39 flank
CgSNF7compF CAAGGACAGTGACAACTTGAGG Amplification of SNF7 for
complementation
CgSNF7compR GTCTCCCCAAGTGGTGGTATG Amplification of SNF7 for
complementation
CgRTSNF7F GGCACACGAGAACGAACTTG Amplification of SNF7 for RT-PCR
CgRTSNF7R GCTCCCTGATCTTGTCCATTG Amplification of SNF7 for RT-PCR
CnRIM101F CGGGCACAAGAAGAGAGAAC Amplification of RIM101 for Real time
CnRIM101R GAGTAAAGAGGCGGCAAATC Amplification of RIM101 for Real time
CnRIM20F CCACTCCTCTTCCTTCTTTCG Amplification of RIM20 for Real time
CnRIM20R TCTCCACCCAATCTTTCCTC Amplification of RIM20 for Real time
CgRIM101F TCCCCTTTCTACCTCAGTTTC Amplification of RIM101 for Real time
CgRIM101R AGCACCAGCATTTCCTTTTG Amplification of RIM101 for Real time
CgRIM20F CAACTCCCCTTCCCTCTTTC Amplification of RIM20 for Real time
CgRIM20R GCCTCTACCCAATCTTTCCTC Amplification of RIM20 for Real time
CnRTACTF CCTTCTACGTCTCTATCCAG Amplification of ACT1 for RT-PCR
CnRTACTR TTTCAAGCTGAGAAGACTGG Amplification of ACT1 for RT-PCR
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 6198 | DOI: 10.1038/srep06198 8
snf7D::SNF7 and CG-snf7D::SNF7) strains were cultivated in YPD medium and
serially diluted75. Diluted cells were spotted in LCM agar, LCM 1 Cu agar and
150 mM LiCl264 (Sigma, St. Louis, MO). Melanin production was visualized in cells
spotted on Niger seed agar plates and on defined media containing 1 mM of L-
DOPA79,80. For capsule analysis, WT, snf7D and complemented strains of C.
neoformans and C. gattii (5 3 106 cells/mL) were incubated using six well culture
plates in DMEM (Invitrogen, Carlsbad, CA) at 37uC and 5% CO2 for 48 hours.
Capsule measurements were performed as previously described76. Staining of surface
components (chitin and GXM) was performed as described elsewhere81. Briefly,
fungal cells were fixed in 4% paraformaldehyde (Sigma, St. Louis, MO) for 1 hour
followed by a incubation with phosphate-buffered saline (PBS) supplemented with
1% bovine serum albumin (Sigma, St. Louis, MO). Cell structures were then stained
using calcofluor white (25 mM) (Sigma, St. Louis, MO) and 18B7 anti GXM
monoclonal antibody (1 mg/mL) (kindly provided by Dr. Arturo Casadevall)
followed by anti murine IgG Alexa Fluor 488 conjugated (Invitrogen, Carlsbad, CA).
Images were acquired using an Axyoplan 2 microscope (Carl Zeiss, Germany). Cell
surface structures were also observed by scanning electron microscopy (SEM) as
described elsewhere67. Analysis of extracellular GXM was performed according to the
method described by Casadevall and colleagues82, with minor modifications83.
Phospholipase activity was determined by using egg yolk agar84,85. Approximately 107
cells of WT, snf7D and complemented strains of both C. neoformans and C. gattii were
spotted onto the center of petri dishes containing egg yolk agar, and incubated at
30uC. After 4 days, the phospholipase activity (Pz value) was determined as described
by Price and colleagues84. To test growth in alkaline pH, YPD medium was buffered
with 150 mM HEPES to pH 7, 7.5, 8, 8.5 and 9 with NaOH. Cultures were serially
diluted in 96-well microtiter plates containing a pH-tested medium. After incubation
at 30uC for 24 hours, absorbance measurements (OD600) were performed using a
ELx80 Absorbance Microplate Reader (BioTek, Winooski, VT) and analyzed using
GraphPad Prism software. Urease activity was evaluated as described by Kwon-
Chung and colleagues86. The measurements (OD560) in urea broth were done at 2, 4
and 24 hours interval. All phenotypic assays were performed in triplicate.
Real time quantitative reverse transcription PCR (RT-qPCR) analysis. Cultures of
WT, snf7D and snf7D::SNF7 strains of C. neoformans and C. gattii were grown
overnight in YPD medium at 30 uC with shaking. RNA extraction and cDNA
synthesis were performed as previously described75 for all strains in this study. The
Applied Biosystems 7500 real-time PCR System (Life Technologies, Carlsbad, CA)
was used for real time PCRs and the PCR cycling conditions as well as melting curve
and relative expression determination were performed as described75. The
experiments were performed using two biological samples and each cDNA sample
was analyzed in triplicate with each primer pair. Actin cDNA levels were used to
normalize each set of PCR experiments. The primer sequences used are listed in the
Table 1.
In vivo assays. Mice were intraperitoneally anesthetized with 100 mg/kg ketamine
and 16 mg/kg xylazine, followed by intranasal infection5 with WT, snf7D and
complemented strains of C. neoformans and C. gattii. For each strain tested, eight
female BALB/c mice (approximately 5 weeks old) were used. Fungal cells were first
grown in YPD medium at 30uC, 200 RPM shaking, during 20 hours. The cells were
washed twice and suspended in PBS solution. The infections were performed by
inoculation of 107 yeast cells suspended in 50 mL PBS per animal. Infected mice were
monitored daily. Mantel-Cox tests were performed using GraphPad Prism software.
For CFU determination and in vivo GXM analysis, groups of 3 female BALB/c mice
(approximately 5 weeks old) were inoculated intratracheally with 107 cells of CN-WT
and CN-snfD strains. After 6 days animals were sacrificed and the lungs were removed
and macerated in 5 mL YPD at 4uC. Macerates were clarified by centrifugation and
supernatants were quantitatively assessed for the presence of GXM by ELISA as
described previously82. Alternatively, 5 mL of the macerates were plated on YPD solid
medium for further incubation at 37uC (48 h) and CFU counting.
Ethics Statement. The Universidade Federal do Rio Grande do Sul Ethics Committee
for Use of Animals (CEUA - protocol number 19801) approved the use of animals in
the present work, which were cared for according to the Brazilian National Council
for Animal Experimentation Control (CONCEA) and Brazilian College of Animal
Experimentation (COBEA) guidelines. Mice were kept in filtered top ventilated cages
with food and water ad libitum. Groups of a maximum number of four mice were kept
in each cage. All efforts to minimize animal suffering and to reduce the number of
animals used were made. Animals were observed twice daily for any signals of
suffering and/or for mortality during 40 days.
Statistical analysis. Statistical comparisons were performed with the Graphpad 5.0
software. Paired comparisons between different groups were performed using the
Student’s t test. Survival curves were statistically analyzed using the Mantel-Cox test.
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